Pär Johansson
8Patents
3h-index
8Co-inventors
46Inventor score
Filing activity: Oct 1, 2008 → Jan 3, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8877710B2 | Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof | Human Necessities | 37 | Active |
| US9433589B2 | Injectable pharmaceutical compositions comprising adrenaline and citric acid | Human Necessities | 9 | Active |
| US9381243B2 | Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof | Human Necessities | 5 | Active |
| US9381166B2 | Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on alfa-adrenergic and/or beta-adrenergic receptors of the sympathetic nervous system, related to improved clot strength | Physics | 3 | Active |
| US9927410B2 | Method and system for detecting urine and/or feces | Human Necessities | 2 | Active |
| US10527633B2 | Composition comprising prostacyclin andor analogues thereof for treatment of acute critically ill patients | Human Necessities | 0 | Active |
| US8428589B2 | Method for reducing signalling | Electricity | 0 | Active |
| US11714094B2 | Composition comprising prostacyclin andor analogues thereof for treatment of acute critically ill patients | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.